women aged older than 60 or 65 years and can be considered for continuation beyond age 65 years for persistent vasomotor symptoms, quality of life issues, or prevention of osteoporosis after appropriate evaluation and counseling of benefits and risks.… There are no data to support routine discontinuation in women age 65 years.”20 This position statement was endorsed by the following groups: Academy of Women’s Health American Association of Clinical Endocrinologists American Association of Nurse Practitioners American Medical Women’s Association American Society for Reproductive Medicine
...more
